Related Experiment Video
Updated: Apr 24, 2026

Evaluation of Cerebral Blood Flow Autoregulation in the Rat Using Laser Doppler Flowmetry
Published on: January 19, 2020
Effects of antihypertensive treatment on cardiovascular autonomic control: a prospective study
Anton R Kiselev1, Vladimir I Gridnev, Mikhail D Prokhorov
1Centre of New Cardiological Informational, Saratov Research Institute of Cardiology, Saratov-Russia. antonkis@list.ru.
Insights
This study introduces a method to personalize antihypertensive treatment for arterial hypertension patients by analyzing heart rate variability and heart rate/photoplethysmogram synchronization. This approach helps tailor medication choices for better autonomic dysfunction control.
Area of Science:
- Cardiology
- Autonomic Nervous System Research
- Hypertension Management
Background:
- Autonomic dysfunction is a key factor in cardiovascular system (CVS) regulation, particularly in patients with arterial hypertension (AH).
- Current antihypertensive treatment (AT) strategies may not fully address individual autonomic dysfunction patterns.
- Personalized medicine approaches are needed to optimize AT based on specific patient physiological markers.
Purpose of the Study:
- To propose an approach for controlling autonomic dysfunction dynamics in the cardiovascular system (CVS) during antihypertensive treatment (AT) for arterial hypertension (AH) patients.
- To utilize individual synchronization features of 0.1-Hz rhythms in heart rate (HR) and photoplethysmogram (PPG), alongside heart rate variability (HRV) spectral indices, for treatment guidance.
- To compare the efficacy of HRV spectral indices and a synchronization index (S) in guiding AT with ACE inhibitors and beta-blockers.
Main Methods:
- Prospective cohort diagnostic accuracy study involving 105 AH patients over 8 weeks.
- Assessment of HRV spectral indices and synchronization index (S) between 0.1-Hz rhythms in HR and PPG during a tilt test.
- Application of Shapiro-Wilk, Mann-Whitney U, and Wilcoxon tests for statistical analysis.
Main Results:
- The power of the low-frequency (LF) band in HRV and index S serve as initial assessment criteria for autonomic regulation in AH patients.
- Specific thresholds for LF and S values during tilt tests indicate the need for ACE inhibitors or beta-blockers.
- Certain patient profiles (e.g., S>25% and LF>250 ms² in horizontal position) may not require ACE-Is or beta-blockers, while others benefit from either drug class.
Conclusions:
- Antihypertensive treatment (AT) control in arterial hypertension (AH) patients can be effectively managed by considering individual autonomic dysfunction characteristics.
- The proposed approach demonstrated a sensitivity of 65% and specificity of 73% in guiding treatment decisions.
- Personalized AT based on autonomic markers offers a more refined strategy for managing AH and associated autonomic dysregulation.
Objective:
The aim of study was to propose an approach to the control of dynamics of autonomic dysfunction in cardiovascular system (CVS) under antihypertensive treatment (AT) in patients with arterial hypertension (AH), based on individual features of synchronization of 0.1-Hz rhythms in heart rate (HR) and photoplethysmogram (PPG) and spectral indices of heart rate variability (HRV).
Methods:
We designed prospective cohort diagnostic accuracy and studied 105 AH patients (66 females) aged 47±8 years during 8 weeks. The HRV spectral indices and the index S of synchronization between the 0.1-Hz rhythms in HR and PPG during a tilt test are compared in their ability to control the AT with angiotensin-converting enzyme inhibitors (ACE-Is) (fosinopril or enalapril) and β-blockers (atenolol or metoprolol). We apply Shapiro-Wilk, Mann-Whitney U and Wilcoxon tests.
Results:
It is shown that the power of low-frequency (LF) band in HRV spectrum and index S can be used as criteria for initial assessment of the status of autonomic regulation in AH patients. The patients with S<25% in vertical body's position and LF>250 ms2 in horizontal body's position require ACE-Is treatment. The AH patients with LF<350 ms2 and S<30% in vertical body's position require β-blocker treatment. The AH patients with S>25% and LF>250 ms2 in horizontal body's position do not require any ACE-Is or β-blocker treatment. Both drug groups can be used in patients with low values of index S and low power of LF band in HRV spectrum.
Conclusion:
The control of AT can be carried out in AH patients taking into account the individual features of autonomic dysfunction in CVS. Sensitivity and specificity of our approach were 65% and 73%, respectively.
More Related Videos
06:30Quantifying Acute Changes in Renal Sympathetic Nerve Activity in Response to Central Nervous System Manipulations in Anesthetized Rats
Published on: September 11, 2018
06:51Development of an Algorithm to Perform a Comprehensive Study of Autonomic Dysreflexia in Animals with High Spinal Cord Injury Using a Telemetry Device
Published on: July 29, 2016
Related Concept Videos
Disorders of the Autonomic Nervous System
Raynaud's disease, also known as Raynaud's...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Neural Regulation of Blood Pressure
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Hypertension and Regulation of Blood Pressure
Pathophysiology of Cardiac Performance
Antihypertensive Drugs: Action of β1 Blockers